PILL:NYE-Direxion Daily Pharmaceutical & Medical Bull 3X Shares ETF (USD)

ETF | Trading--Leveraged Equity |

Last Closing

USD 8.21

Change

+0.10 (+1.23)%

Market Cap

N/A

Volume

0.05M

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-01-29 )

Largest Industry Peers for Trading--Leveraged Equity

Symbol Name Price(Change) Market Cap
SOXL Direxion Daily Semiconductor B..

+0.31 (+1.22%)

USD 9.17B
FNGU MicroSectors FANG+ Index 3X Le..

-18.52 (-2.80%)

USD 7.31B
QLD ProShares Ultra QQQ

-0.45 (-0.40%)

USD 6.67B
SSO ProShares Ultra S&P500

-0.88 (-0.90%)

USD 5.30B
UPRO ProShares UltraPro S&P500

-1.32 (-1.37%)

USD 4.36B
TECL Direxion Daily Technology Bull..

-2.17 (-2.43%)

USD 3.10B
YINN Direxion Daily FTSE China Bull..

-0.31 (-0.98%)

USD 1.32B
USD ProShares Ultra Semiconductors

-2.08 (-3.62%)

USD 1.15B
UDOW ProShares UltraPro Dow30

-0.89 (-0.81%)

USD 0.85B
DPST Direxion Daily Regional Banks ..

-0.62 (-0.49%)

USD 0.83B

ETFs Containing PILL

N/A

Market Performance

  Market Performance vs. Industry/Classification (Trading--Leveraged Equity) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 15.63% 84% B 96% N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return 15.63% 84% B 96% N/A
Trailing 12 Months  
Capital Gain 4.99% 21% F 48% F
Dividend Return 1.00% 47% F 14% F
Total Return 5.98% 21% F 38% F
Trailing 5 Years  
Capital Gain -66.26% 20% F 6% D-
Dividend Return 1.15% 16% F 4% F
Total Return -65.10% 17% F 5% F
Average Annual (5 Year Horizon)  
Capital Gain 57.61% 79% B- 95% A
Dividend Return 58.18% 79% B- 94% A
Total Return 0.57% 41% F 14% F
Risk Return Profile  
Volatility (Standard Deviation) 392.93% 15% F 3% F
Risk Adjusted Return 14.81% 25% F 30% F
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
High dividend returns

The stock has outperformed its sector peers on average annual dividend returns basis in the past 5 years (for a hold period of at least 12 months) and is in the top quartile. This can be a good buy, especially if it is outperforming on total return basis , for investors seeking high income yields.

What to not like:
Poor risk adjusted returns

This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.

Below median total returns

The company has under performed its peers on annual average total returns in the past 5 years.

High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.